ConductScience.org, home

Paper33430278

The Next Generation of Influenza Vaccines: Towards a Universal Solution.

McMillan CLD and 3 others. Vaccines (Basel), 2021. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. The Next Generation of Influenza Vaccines: Towards a Universal Solution. Papers, record 33430278. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33430278

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Next Generation of Influenza Vaccines: Towards a Universal Solution.
PubMed
Journal
Vaccines (Basel)
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.57
iCite
Revised in PubMed
2021-02-18
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McMillan CLDChristopher L Dhttps://orcid.org/0000-0002-5316-0986
2Young PRPaul R
3Watterson DDaniel
4Chappell KJKeith J

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References129

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126641724Strategies towards universal pandemic influenza vaccines.Expert Rev Vaccines2016https://conductscience.org/library/papers/26641724PubMed
219840661M2e-based universal influenza A vaccine.Vaccine2009https://conductscience.org/library/papers/19840661PubMed
326167164Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 Subtype.Front Immunol2015https://conductscience.org/library/papers/26167164PubMed
430764577Emerging Influenza D Virus Threat: What We Know so Far!J Clin Med2019https://conductscience.org/library/papers/30764577PubMed
520870054Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.Vaccine2010https://conductscience.org/library/papers/20870054PubMed
619135117A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.Vaccine2009https://conductscience.org/library/papers/19135117PubMed
724595369Characterization of a novel influenza virus in cattle and Swine: proposal for a new genus in the Orthomyxoviridae family.mBio2014https://conductscience.org/library/papers/24595369PubMed
829992986The influenza virus hemagglutinin head evolves faster than the stalk domain.Sci Rep2018https://conductscience.org/library/papers/29992986PubMed
911294672Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus.J Infect Dis2001https://conductscience.org/library/papers/11294672PubMed
1019729082Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.Vaccine2009https://conductscience.org/library/papers/19729082PubMed
1129100705Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine.Vaccine2018https://conductscience.org/library/papers/29100705PubMed
1223029232Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.PLoS One2012https://conductscience.org/library/papers/23029232PubMed
1323991187Low seroprevalent species D adenovirus vectors as influenza vaccines.PLoS One2013https://conductscience.org/library/papers/23991187PubMed
149682352Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.Vaccine1998https://conductscience.org/library/papers/9682352PubMed
1526549362Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine.Vaccine2015https://conductscience.org/library/papers/26549362PubMed
1624279313Adenovirus vectors for gene therapy, vaccination and cancer gene therapy.Curr Gene Ther2013https://conductscience.org/library/papers/24279313PubMed
1726026378Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses.Vaccine2015https://conductscience.org/library/papers/26026378PubMed
1825695754Reassortant highly pathogenic influenza A(H5N6) virus in Laos.Emerg Infect Dis2015https://conductscience.org/library/papers/25695754PubMed
197464906Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.Nature1981https://conductscience.org/library/papers/7464906PubMed
2033288923A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.Nat Med2021https://conductscience.org/library/papers/33288923PubMed

See all 129 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42722670Single-component self-assembling protein nanoparticles displaying stabilized prefusion-closed hemagglutinin trimers for influenza vaccine development.Nat Commun2026https://conductscience.org/library/papers/42722670PubMed
42645432Advances in the Development of a Universal Influenza Vaccine.Antibodies (Basel)2026https://conductscience.org/library/papers/42645432PubMed
41279549Mucosal delivery of influenza antigens using a replication deficient adenovirus supports broadly reactive antibody responses and heterologous viral immunity in the respiratory tract of animals.bioRxiv2025https://conductscience.org/library/papers/41279549PubMed
41012618Use of the Slow-Delivery Platform, VacSIM, Shapes the Host Immune Response to Increase Protection Against Influenza Infection.Viruses2025https://conductscience.org/library/papers/41012618PubMed
39360831Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials.Clin Microbiol Rev2024https://conductscience.org/library/papers/39360831PubMed
39111250A broad-spectrum multiepitope vaccine against seasonal influenza A and B viruses in mice.EBioMedicine2024https://conductscience.org/library/papers/39111250PubMed
38793789DNA Vaccine Encoding a Modified Hemagglutinin Trimer of Avian Influenza A Virus H5N8 Protects Mice from Viral Challenge.Vaccines (Basel)2024https://conductscience.org/library/papers/38793789PubMed
38793788Very Broadly Effective Hemagglutinin-Directed Influenza Vaccines with Anti-Herpetic Activity.Vaccines (Basel)2024https://conductscience.org/library/papers/38793788PubMed
38430907Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase.Immunity2024https://conductscience.org/library/papers/38430907PubMed
37988765Single-Component Multilayered Self-Assembling Protein Nanoparticles Displaying Extracellular Domains of Matrix Protein 2 as a Pan-influenza A Vaccine.ACS Nano2023https://conductscience.org/library/papers/37988765PubMed
37338377A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection.J Virol2023https://conductscience.org/library/papers/37338377PubMed
37293549Temperature impacts Atlantic salmon's (Salmo salar) immunological response to infectious salmon anemia virus (ISAv).Fish Shellfish Immunol Rep2023https://conductscience.org/library/papers/37293549PubMed
36721506Assessment of influenza A (H1N1, H3N2) oseltamivir resistance during 2017-2019 in Iran.Iran J Microbiol2022https://conductscience.org/library/papers/36721506PubMed
36258770Identification of antigens recognized by salivary IgA using microbial protein microarrays.Biosci Microbiota Food Health2022https://conductscience.org/library/papers/36258770PubMed
35089583Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2.J Microbiol2022https://conductscience.org/library/papers/35089583PubMed
34696304Fear of Influenza Resurgence amid COVID-19 Pandemic: Need for Effective Flu Vaccine Still Exists.Vaccines (Basel)2021https://conductscience.org/library/papers/34696304PubMed
34576851A Small Virus to Deliver Small Antibodies: New Targeted Therapies Based on AAV Delivery of Nanobodies.Microorganisms2021https://conductscience.org/library/papers/34576851PubMed
34372526Targeting Viral Surface Proteins through Structure-Based Design.Viruses2021https://conductscience.org/library/papers/34372526PubMed
34202178Conserved Influenza Hemagglutinin, Neuraminidase and Matrix Peptides Adjuvanted with ALFQ Induce Broadly Neutralizing Antibodies.Vaccines (Basel)2021https://conductscience.org/library/papers/34202178PubMed
33916924Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses.Vaccines (Basel)2021https://conductscience.org/library/papers/33916924PubMed

Download CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33430278

GET https://conductscience.org/api/papers/v1/33430278/references?page=2